Browsing: MOASC

Introduction to a Revolutionary Cancer Approach This treatment starts with T cells from the patient. Doctors add receptors to spot…

Immune checkpoint inhibitors myocarditis poses a serious threat in cancer care. These drugs fight tumors well. However, they can inflame…

TIL Therapy Breakthroughs for Oncologists and Oncology Professionals Tumor-Infiltrating Lymphocyte (TIL) therapy is transforming melanoma care and continues to provide…

Introduction to Neoadjuvant Therapy for Melanoma Neoadjuvant therapy is changing how we treat melanoma, offering big benefits over traditional adjuvant…

On September 6, 2025, at the MOASC and ANCO Immuno-Oncology Symposium, Dr. Alexis LeVee, MD, from UCLA’s Division of Hematology/Oncology,…

Introduction to ASCO 2025 Lung Cancer Immunotherapy Updates At the MOASC/ANCO Immuno-Oncology Symposium held on September 6, 2025, in Marina…

Uncommon EGFR Mutations Research Overview At MOASC Spotlight 2025, Dr. Darren Wijaya, MD, from Loma Linda University Health, shared vital…

Oncology changes quickly. The melanoma treatment updates 2025 from the ASCO Annual Meeting offer vital help. Dr. Gino K. In,…

Paraneoplastic syndromes can signal hidden cancers. Dr. Nirja Shah, MD, from UC San Diego Health, shared a rare case study.…

At the MOASC Spotlight 2025 in Newport, California, Dr. Victoria M. Villaflor, MD, shared exciting head and neck cancer ASCO…

Gastric cancer immunotherapy is advancing rapidly, bringing hope for better patient outcomes. Therefore, OncologyTube is excited to share insights from…

The ASCO 2025 breast cancer updates revealed exciting changes in treatment for triple-negative breast cancer (TNBC) and HER2-low cases. For…

At the 2025 MOASC Spotlight in Newport Beach, CA, Dr. Miguel Villalona-Calero, MD, from the University of California Irvine, shared…

At the MOASC Spotlight 2025, Dr. Joshua G. Cohen, M.D., F.A.C.O.G., F.A.C.S., Medical Director of the Gynecologic Cancer Program at City…

ASCO 2025 and the MOASC Conference unveiled major progress in colon cancer treatment advancements. For example, the CHALLENGE study showed…

Genitourinary oncology is advancing fast. At the MOASC Spotlight on Oncology event on August 16, 2025, at VEA Newport Beach,…

April 06, 2025 | By Nataliya Mar, MD, Associate Professor, UC Irvine The American Society of Clinical Oncology Genitourinary Cancers…

By Samuel Zeng, MD – UCLAPosted on April 4, 2025 When chest pain strikes a patient with a history of…

By: Neil Chawla, MD – Oncologist and Researcher at the Cancer Center of SouthernCalifornia and Sarcoma Oncology Center Introduction to…

By: Hamid Mirshahidi, MD – Loma Linda University The AACR 9th Edition has introduced significant changes to the TNM staging…

In the 2025 MOASC Breast Cancer Updates, Evanthia Roussos Torres, MD, delivers a compelling overview of the current challenges and…

2025 Leukemia and Lymphoma Updates: Clarkson’s Disease, Myeloma, and MDS Treatments The field of hematology is witnessing remarkable advancements, offering…

Introduction: A Milestone Achievement for Dr. Peter Zang Peter Zang, MD, a second-year fellow at City of Hope, has reached…

MOASC: Medical Oncology Association of Southern California Welcome to MOASC’s Digital Presence on OncologyTube The Medical Oncology Association of Southern…

… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set a benchmark in oncology, providing…

The MOASC represents a prestigious accolade designed to recognize and encourage promising young researchers in the field of oncology. This…

… At the MOASC Annual Oncology Summit & Research Symposium, Dr. Karen Reckamp, MD, MS, a leading figure in medical…

… Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic options. Dr. Justin T.…

… The field of oncology is witnessing a paradigm shift in the treatment of lymphomas, fueled by the emergence of…

… In the rapidly evolving field of oncology, colorectal cancer (CRC) represents a significant area of research and clinical development.…

… [VIDEO & SLIDES] Alex Chehrazi –Raffle, MD, City of Hope – 2024 MOASC Annual Oncology Summit & Research Symposium…

… [VIDEO with 39 SLIDES] – Dr. Rebecca Shatsky, MD from the 2024 MOASC Annual Oncology Summit & Research Symposium…

Introduction to Myelofibrosis and JAK Inhibitors Myelofibrosis, a complex myeloproliferative neoplasm, presents a unique set of challenges for both patients…

Zahra Pakbaz, MD, shed light on a range of critical findings from the American Society of Hematology (ASH) meeting, with…

In 2024, CAR T-cell therapy continues to transform the landscape of treatment for hematologic malignancies, including multiple myeloma and various…

ASH Groundbreaking Trials and Therapies Transform Multiple Myeloma Treatment The recent American Society of Hematology (ASH) meeting showcased significant advancements…

By. Kim Margolin, MDDate. 11/17/2023In the field of cancer immunotherapy, Kim Margolin, MD, provides insights into the interplay between the…

Elizabeth Brem , MD discusses the design and outcomes of the study referred to as 1826. The study aimed to…

Shirin Attarian, MD addresses the escalating incidence of head and neck cancer and highlights that most cases, particularly oropharyngeal cancers,…

Jalen Patel, MD – City of Hopeaugust 21, 2023Drawing from data provided by ASCO and Friends of Cancer Research, the…

Presented By: Brian Warnecke, DO – UC-Irvine Hematology Oncology Fellow, PGY-5 Date: August 12, 2023The presentation titled “Multi-omic Characterization of…

The “MOASC SPOTLIGHT ON ONCOLOGY – GU ASCO UPDATES” seminar, led by Dr. Nataliya Mar, Clinical Associate Professor in the…

Dr. Sayeh Lavasani, MD, MSc, FRCPC, an Associate Clinical Professor in the Division of Hematology Oncology at the Department of…

Renal Cell Carcinoma Trials: Guidelines and Eligibility According to ASCO-FCR: An Overview of RCC Trials Anna Odell by Anna Odell,…

Renal Cell Carcinoma Trials: ASCO-FCR Guidelines for Renal Cell Carcinoma Trial Eligibility Ishann Sehgal by Ishann Sehgal, City of Hope…

HER2 Low Breast Cancer: What Are the Latest Advancements in Novel Drug Antibody Conjugates for 2023? Yuan Yuan MD By…

Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD By Ravi Salgia, MD,…

Urothelial Cancer: What’s New in 2023? Targeted and Novel Therapies Nataliya Mar MD By Nataliya Mar, MD Good afternoon, everyone.…

Insights on Breast Cancer Treatment: Yuan Yuan, MD’s Discussion on Sacituzumab Govitecan and Other Novel Treatments By Yuan Yuan, MD,…

How effective is mosunetuzumab in treating lymphoma? – Elizabeth Budde, MD 2023 reviews new therapies By Elizabeth Budde, Md, PhD…

Belzutifan and other Novel Therapies in Genitourinary Oncology 2023 By Rana McKay, MD – University of California San Diego We’re…

Gastrointestinal Malignancies Research Advancements: Insights from Farshid Dayyani, MD By Farshid Dayyani, MD, PhD Thank you so much for inviting…

Health Inequity in Cancer Research: Examining and Uncovering the Disparities by Hala Borno MD By Hala Borno, MD What also…

2023 ASH BCMA & Multiple Myeloma Updates with Slides by: Lisa Lee, MD – Assistant Professor — Division of Hematology-Oncology, Department…

ASH Meeting 2022 – Hematopoietic Stem Cell Transplantation with Tacrolimus Updates By Stefan O. Ciurea, MD from UCI Health So…

What ASH abstracts stood out to you most in multiple myeloma? By Lisa X. Lee, MD from UCI Health At…

Myelodysplastic Syndromes Treatment Update for 2023 By Deepa Jeyakumar, MD from UCI Health I think what’s very exciting is that…

Zanubrutinib compared to ibrutinib in chronic lymphocytic leukemia By Elizabeth Brém, MD from UCI Health We focused basically on two…

Women with recurrent miscarriage were treated with low molecular weight heparin versus usual pregnancy care By Zahra Pakbaz, MD from…

ASH Meeting 2022 – Hematopoietic Stem Cell Transplantation with Tacrolimus UpdatesBy: Stefan O. Ciurea, MD – Director, Hematopoietic Stem Cell…

iFrame is not supported! Inotuzumab and MRD Understanding the Importance of Targeted Therapy in Cancer Treatment Summarized from Van Huynh,…

Myelodysplastic Syndromes Treatment Update for 2023 ASH AML Inotuzumab Update [Slides] – Kiran Naqvi, MD MOASC By Kiran Naqvi, MD…

MRD: Inotuzumab, GMALL, Ponatinib & Blinatumomab ASH Updates in Acute Lymphoblastic Leukemia/Immunotherapy By Van Huynh, MD Today I spoke at…

Myelodysplastic Syndromes Treatment Update for 2023 So briefly with regard to myelodysplastic syndromes MDS, I just wanted to discuss some…

Inotuzumab, GMALL, Ponatinib & Blinatumomab ASH Updates in Acute Lymphoblastic Leukemia By Van Huynh, MD Updates in acute lymphoblastic leukemia…

Zanubrutinib compared to ibrutinib in chronic lymphocytic leukemia So I’m gonna start with chronic lymphocytic leukemia. And as part of…

2023 ASH Pregnancy Update Slides Etavopivat treatment Low molecular weight heparin versus a standard pregnancy care for women with recurrent…

2023 ASH AML Updates [Slides] – Kiran Naqvi MD – MOASC Acute myeloid leukemia updates from our recent ASH from…

ASCO [2022] Lung Cancer In-Depth Slides: MOASC Dr. Misako Nagasaka’s (thoracic oncology) MOASC Presentation on ASCO (Annual Meeting, American…

ASCO (American Society of Clinical Oncology) [2022] Sarcomas Cancer In-Depth Slides: MOASC   Dr. Warren Chow’s MOASC Presentation on ASCO…

Question and Answer Session Dr. Misako Nagasaka – ASCO [2022] Lung Cancer In-Depth Slides: MOASC Presentation https://oncologytube.com/v/41320 Misako Nagasaka, MD…

Question and Answer Session Kay Yeung, MD, Ph.D. – ASCO [2022] Breast Cancer In-Depth Slides: MOASC https://oncologytube.com/v/41294 Kay Yeung, MD,…

Question and Answer Session Justin Moyers, MD – ASCO 2022 Melanoma Overview: MOASC Spotlight https://oncologytube.com/v/41283 Justin Moyers, MD Exit Interview…

Question and Answer Session Joseph Chao, MD – ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight https://oncologytube.com/v/41288 Joseph Chao, MD -…

Question and Answer Session   Warren Chow, MD – ASCO [2022] Sarcomas Cancer In-Depth Slides: MOASC https://oncologytube.com/v/41319 Warren Chow, MD…

Question and Answer Session Arash Rezazadeh, MD, ASCO [2022] Genitourinary Cancer: MOASC Oncology Spotlight Link https://oncologytube.com/v/41291 Arash Rezazadeh, MD, ASCO…

Question and Answer Session  May Cho, MD – ASCO 2022 Colon Cancer In-Depth Slides: MOASC Spotlight Link https://oncologytube.com/v/41298 May Cho,…

Anemia and Zinc Deficiency [2022]: MOASC Spotlight   Zachary Hanson, DO MOASC Poster on Anemia Zinc Deficiency 2022 Hi, I’m…

Cancer and COVID-19: Thrombosis and Pro-inflammatory (cytokines)   Christopher Grant, MD, MOASC Poster on Cancer and COVID-19: Thrombosis and Pro-inflammatory…

Paraneoplastic Glomerular Nephropathy [2022]: MOASC   Xiaojie Zhang, MD Poster On Paraneoplastic Glomerular Nephropathy Hi, I’m Xiaojie Zhang, and I’m…

ASCO 2022 Colon Cancer In-Depth Slides: MOASC Spotlight   May Cho, MD from UCI Health ASCO (American Society of Clinical…

ASCO [2022] Breast Cancer In-Depth Slides: MOASC   Kay Yeung, MD, Ph.D. Delivers Her MOASC 2022 Breast Cancer Presentation Hello,…

ASCO [2022] Genitourinary Cancer(s): MOASC Oncology Spotlight Dr. Arash Rezazadeh’s MOASC 2022 Presentation in Genitourinary Cancers (ASCO genitourinary cancers symposium)…

ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight   ASCO 2022 Esophageal Cancer Abstracts Highlights Abstracts of interest that were recently…

Cholangiocarcinoma: Ipilimumab and Nivolumab Combo   MOASC Poster Session 2022 (Cholangiocarcinoma Ipilimumab Nivolumab) Hello, my name is Dalia Kaakour (clinical…

ASCO 2022 Prostate Cancer Overview: MOASC Spotlight   ARASENS Trial I presented at MOASC three datasets in prostate cancer from…

ASCO (American Society of Clinical Oncology) 2022 Colon Cancer Overview: MOASC Spotlight   Today I presented three clinical trials at…

ASCO 2022 Melanoma Overview: MOASC Spotlight   KEYNOTE-716 Study   Today, we talked about some of the exciting new discoveries…